Current issue
Archive
Manuscripts accepted
About the Journal
Editorial office
Editorial board
Section Editors
Abstracting and indexing
Subscription
Contact
Ethical standards and procedures
Most read articles
Instructions for authors
Article Processing Charge (APC)
Regulations of paying article processing charge (APC)
CLINICAL RESEARCH
Predictive value of the -1031T/C polymorphism in the tumor necrosis factor-α gene for malnutrition prediction in patients with adenocarcinoma of the esophagogastric junction
1
Department of Abdominal Tumor Surgery, Anyang Tumor Hospital, Anyang, China
These authors had equal contribution to this work
Submission date: 2024-10-26
Final revision date: 2025-03-27
Acceptance date: 2025-04-01
Online publication date: 2025-04-25
Corresponding author
KEYWORDS
adenocarcinoma of esophagogastric junctionmalnutritionTNF-αgene single nucleotide polymorphismsnutritional therapy
TOPICS
ABSTRACT
Introduction:
The prevalence of malnutrition in patients with locally advanced adenocarcinoma of the gastroesophageal junction (AEG) is remarkably high, and it significantly influences the prognosis beyond treatment outcomes and postoperative complications. This study aimed to investigate the potential of TNF-α-1031 T/C gene polymorphism as a predictive biomarker for malnutrition in AEG patients, as well as its efficacy in predicting oral nutritional therapy.
Material and methods:
The study included 243 patients with locally advanced AEG. DNA genotyping analysis using SNP1 software was conducted on the tailoring DNA. Patients identified as high risk for malnutrition prior to treatment received concurrent oral nutritional therapy alongside neoadjuvant chemotherapy over a period of 7–9 weeks.
Results:
Compared to patients carrying the TT genotype, those harboring the C allele exhibited a significantly higher susceptibility to developing malnutrition. Furthermore, there was a substantial increase in the susceptibility to malnutrition. Multivariate regression analysis revealed that carrying the C allele independently serves as a prognostic factor for malnutrition in AEG patients. Furthermore, our findings suggest that the C allele acts as an independent prognostic factor for improved nutritional status following oral nutritional therapy.
Conclusions:
The TNF-α SNP (-1031 T/C) has been identified as an independent prognostic factor associated with malnutrition in patients with advanced AEG. Patients carrying the C allele exhibited a significantly poorer nutritional status compared to those with the TT genotype. Moreover, in the context of neoadjuvant chemotherapy combined with oral nutritional therapy, the nutritional status of C allele carriers was significantly poorer compared to that of TT genotype patients.
The prevalence of malnutrition in patients with locally advanced adenocarcinoma of the gastroesophageal junction (AEG) is remarkably high, and it significantly influences the prognosis beyond treatment outcomes and postoperative complications. This study aimed to investigate the potential of TNF-α-1031 T/C gene polymorphism as a predictive biomarker for malnutrition in AEG patients, as well as its efficacy in predicting oral nutritional therapy.
Material and methods:
The study included 243 patients with locally advanced AEG. DNA genotyping analysis using SNP1 software was conducted on the tailoring DNA. Patients identified as high risk for malnutrition prior to treatment received concurrent oral nutritional therapy alongside neoadjuvant chemotherapy over a period of 7–9 weeks.
Results:
Compared to patients carrying the TT genotype, those harboring the C allele exhibited a significantly higher susceptibility to developing malnutrition. Furthermore, there was a substantial increase in the susceptibility to malnutrition. Multivariate regression analysis revealed that carrying the C allele independently serves as a prognostic factor for malnutrition in AEG patients. Furthermore, our findings suggest that the C allele acts as an independent prognostic factor for improved nutritional status following oral nutritional therapy.
Conclusions:
The TNF-α SNP (-1031 T/C) has been identified as an independent prognostic factor associated with malnutrition in patients with advanced AEG. Patients carrying the C allele exhibited a significantly poorer nutritional status compared to those with the TT genotype. Moreover, in the context of neoadjuvant chemotherapy combined with oral nutritional therapy, the nutritional status of C allele carriers was significantly poorer compared to that of TT genotype patients.
REFERENCES (35)
1.
Raptis D, Maak M, Krautz C, et al. Surgical and oncological outcome after extended lymph node dissection for carcinoma of the stomach and the esophagogastric junction: a retrospective analysis from an experienced single center. Arch Med Sci 2021; 20: 124-32.
2.
Zhao Q, Li Y, Yu B, et al. Effects of preoperative enteral nutrition on postoperative recent nutritional status in patients with Siewert II and III adenocarcinoma of esophagogastric junction after neoadjuvant chemoradiotherapy. Nutr Cancer 2018; 70: 895-903.
3.
Metsovitis T, Bernardi M, Bruckert E, et al. Role of nutrition and healthy lifestyle, for individuals in primary prevention: recent data, gaps in evidence and future directions. Arch Med Sci 2024; 20: 1385-99.
4.
Cederholm T, Jensen GL, Correia MITD, et al. GLIM criteria for the diagnosis of malnutrition - a consensus report from the global clinical nutrition community. Clin Nutr 2019; 38: 1-9.
5.
Nishikawa H, Goto M, Fukunishi S, et al. Cancer cachexia: its mechanism and clinical significance. Int J Mol Sci 2021; 22: 8491.
6.
Powrózek T, Mlak R, Brzozowska A, et al. Relationship between TNF- -1031T/C gene polymorphism, plasma level of TNF-, and risk of cachexia in head and neck cancer patients. J Cancer Res Clin Oncol 2018; 144: 1423-34.
7.
Cai D, Frantz JD, Tawa NE Jr, et al. IKKbeta/NF-kappaB activation causes severe muscle wasting in mice. Cell 2004; 119: 285-98.
8.
Siddiqui JA, Pothuraju R, Jain M, et al. Advances in cancer cachexia: intersection between affected organs, mediators, and pharmacological interventions. Biochim Biophys Acta Rev Cancer 2020; 1873: 188359.
9.
Wang YF, An ZY, Lin DH, et al. Targeting cancer cachexia: molecular mechanisms and clinical study. MedComm 2022; 3: e164.
10.
Zeng X, Liu L, Zheng M, et al. Pantoprazole, an FDA-approved proton-pump inhibitor, suppresses colorectal cancer growth by targeting T-cell-originated protein kinase. Oncotarget 2016; 7: 22460-73.
11.
Sadaf T, John P, Bhatti A, Malik JM. Lack of association of -863C/A (rs1800630) polymorphism of tumor necrosis factor-a gene with rheumatoid arthritis. Arch Med Sci 2019; 15: 531-6.
12.
Homa-Mlak I, Mlak R, Mazurek M, et al. TNFRSF1A gene polymorphism (610 T > G, rs4149570) as a predictor of malnutrition and a prognostic factor in patients subjected to intensity-modulated radiation therapy due to head and neck cancer. Cancers (Basel) 2022; 14: 3407.
13.
Johns N, Tan BH, MacMillan M, et al. Genetic basis of interindividual susceptibility to cancer cachexia: selection of potential candidate gene polymorphisms for association studies. J Genet 2014; 93: 893-916.
14.
Santos NCD, Gomes TN, Góis IAF, et al. Association of single nucleotide polymorphisms in TNF- (-308G/A and -238G/A) to dengue: case-control and meta-analysis study. Cytokine 2020; 134: 155183.
15.
Khodadadi A, Ghadiri A, Ghafourian M, et al. The TNF--308G/A gene polymorphism and serum TNF- levels in women with preeclampsia. J Family Reprod Health 2022; 16: 205-11.
16.
Younis S, Shamim S, Nisar K, et al. Association of TNF- polymorphisms (-857, -863 and -1031), TNF- serum level and lipid profile with acne vulgaris. Saudi J Biol Sci 2021; 28: 6615-20.
17.
Mlak R, Powrózek T, Brzozowska A, et al. The relationship between TNF- gene promoter polymorphism (- 1211 T > C), the plasma concentration of TNF-, and risk of oral mucositis and shortening of overall survival in patients subjected to intensity-modulated radiation therapy due to head and neck cancer. Support Care Cancer 2020; 28: 531-40.
18.
Sadaf T, John P, Bhatti A, et al. Lack of association of -863C/A (rs1800630) polymorphism of tumor necrosis factor-a gene with rheumatoid arthritis. Arch Med Sci 2019; 15: 531-6.
19.
Johns N, Stretch C, Tan BH, et al. New genetic signatures associated with cancer cachexia as defined by low skeletal muscle index and weight loss. J Cachexia Sarcopenia Muscle 2017; 8: 122-30.
20.
Nourian M, Chaleshi V, Pishkar L, et al. Evaluation of tumor necrosis factor (TNF)- mRNA expression level and the rs1799964 polymorphism of the TNF- gene in peripheral mononuclear cells of patients with inflammatory bowel diseases. Biomed Rep 2017; 6: 698-702.
21.
Fu L, Lei C, Chen Y, et al. TNF-alpha-1031T/C gene polymorphism as a predictor of malnutrition in patients with gastric cancer. Front Nutr 2023; 10: 1208375.
22.
Kondrup J, Rasmussen HH, Hamberg O, et al. Nutritional risk screening (NRS 2002): a new method based on an analysis of controlled clinical trials. Clin Nutr 2003; 22: 321-36.
23.
Rice TW, Ishwaran H, Ferguson MK, et al. Cancer of the esophagus and esophagogastric junction: an eighth edition staging primer. J Thorac Oncol 2017; 12: 36-42.
24.
Chen L, Hu J, Ji J, et al. Chinese expert consensus on the surgical treatment for adenocarcinoma of esophagogastric junction (2018 edition). Zhonghua Wei Chang Wai Ke Za Zhi 2018; 21: 961-75.
25.
Zhilong W, Lei T, Ziyu L, et al. Application value of multi-detector computed tomography evaluating the clinical staging of adenocarcinoma of the esophagogastric junction after neoadjuvant chemotherapy. Chin J Dig Surg 2018; 17: 861-8.
26.
Neeman E, Gresham G, Ovasapians N, et al. Comparing Physician and Nurse Eastern Cooperative Oncology Group Performance Status (ECOG-PS) ratings as predictors of clinical outcomes in patients with cancer. Oncologist 2019; 24: e1460-6.
27.
Yin L, Lin X, Zhao Z, et al. Is hand grip strength a necessary supportive index in the phenotypic criteria of the GLIM-based diagnosis of malnutrition in patients with cancer? Support Care Cancer 2021; 29: 4001-13.
28.
Braga M, Ljungqvist O, Soeters P, et al. ESPEN guidelines on parenteral nutrition: surgery. Clin Nutr 2009; 28: 378-86.
29.
Barbosa-Silva MC, Barros AJ. Indications and limitations of the use of subjective global assessment in clinical practice: an update. Curr Opin Clin Nutr Metab Care 2006; 9: 263-9.
30.
Zhou T, Yang K, Thapa S, et al. Differences in symptom burden among cancer patients with different stages of cachexia. J Pain Symptom Manage 2017; 53: 919-26.
31.
Barreira JV. The role of nutrition in cancer patients. Nutr Cancer 2021; 73: 2849-50.
32.
Dijksterhuis WPM, Latenstein AEJ, van Kleef JJ, et al. Cachexia and dietetic interventions in patients with esophagogastric cancer: a multicenter cohort study. J Natl Compr Canc Netw 2021; 19: 144-52.
33.
Gao X, Liu H, Zhang L, et al. The application value of preoperative fat-free mass index within Global Leadership Initiative on Malnutrition-defined malnutrition criteria for postoperative outcomes in patients with esophagogastric cancer. Nutrition 2022; 102: 111748.
34.
Correia M, Cravo M, Marques-Vidal P, et al. Serum concentrations of TNF-alpha as a surrogate marker for malnutrition and worse quality of life in patients with gastric cancer. Clin Nutr 2007; 26: 728-35.
35.
Kim J, Lee J, Choi IJ, et al. TNF genetic polymorphism (rs1799964) may modify the effect of the dietary inflammatory index on gastric cancer in a case-control study. Sci Rep 2020; 10: 14590.
Share
RELATED ARTICLE
| eISSN: | 1896-9151 |
| ISSN: | 1734-1922 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
